Valion Bio, Inc. (VBIO) — Institutional Holders, Q2 2026
13 institutional investment managers reported a VBIO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $205.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
VBIO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Murchinson Ltd.New · +115,000 sh+$59.8K
- CITADEL ADVISORSNew · +74,145 sh+$38.5K
- Virtu FinancialNew · +39,225 sh+$20.4K
- TWO SIGMA SECURITIESNew · +10,162 sh+$5.3K
- UBS Group AGAdded · +8,728 sh+$4.5K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -68,444 sh-$35.6K
- HRT FINANCIALTrimmed · -30,957 sh-$16.1K
- XTX Topco LtdSold out · -10,506 sh-$5.5K
- Marex Group plcTrimmed · -4,976 sh-$2.6K
VBIO 13F holders ranked 1–13 of 13
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Murchinson Ltd.#1 · 115,000 sh | 115,000 | $59.8K | <0.01% | New |
| 2 | CITADEL ADVISORS#2 · 74,145 sh | 74,145 | $38.5K | 0.00% | New |
| 3 | Sanctuary Advisors#3 · 61,205 sh | 61,205 | $31.8K | <0.01% | 0.0% |
| 4 | Marex Group plc#4 · 54,287 sh | 54,287 | $28.2K | <0.01% | -8.4% |
| 5 | Virtu Financial#5 · 39,225 sh | 39,225 | $20.0K | <0.01% | New |
| 6 | GEODE CAPITAL MANAGEMENT#6 · 19,374 sh | 19,374 | $10.1K | 0.00% | -77.9% |
| 7 | UBS Group AG#7 · 11,094 sh | 11,094 | $5.8K | 0.00% | +368.9% |
| 8 | TWO SIGMA SECURITIES#8 · 10,162 sh | 10,162 | $5.3K | <0.01% | New |
| 9 | HRT FINANCIAL#9 · 11,462 sh | 11,462 | $5.0K | 0.00% | -73.0% |
| 10 | Tower Research Capital (TRC)#10 · 2,095 sh | 2,095 | $1.1K | 0.00% | +258.7% |
| 11 | SBI Securities , Ltd.#11 · 16 sh | 16 | $8.00 | — | 0.0% |
| 12 | TD Waterhouse Canada#12 · 5 sh | 5 | $2.00 | — | New |
| 13 | Caitong International Asset Management , Ltd#13 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of VBIO in Q2 2026 (1)
Held VBIO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd10,506 sh | 10,506 | $9.3K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.